PT-141 (bremelanotide) is a synthetic peptide used to treat sexual dysfunction in both men and women by directly stimulating the nervous system to enhance libido, arousal, and desire. It offers a non-invasive, fast-acting solution for HSDD (hypoactive sexual desire disorder) in premenopausal women and erectile dysfunction (ED) in men, often acting within minutes to hours.
Key Benefits of PT-141
Improved Sexual Function (Men): It supports on-demand erections and improved erectile function, making it an alternative for men who do not respond to traditional ED medications.
Treatment for HSDD (Women): It is FDA-approved for treating acquired, generalized Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Fast-Acting and Long-Lasting: Effects can be felt within 30 minutes to a few hours, with benefits potentially lasting up to 24–72 hours.
Increased Confidence and Reduced Anxiety: It can help reduce sexual anxiety, leading to improved confidence and better emotional connection with a partner.
Enhanced Sexual Desire and Libido:
 Unlike PDE5 inhibitors (e.g., Viagra) that focus on blood flow, PT-141 acts on the brain's melanocortin receptors, addressing the mental and emotional components of sexual desire